Computerised Systems in Pharmaceuticals

download Computerised Systems in Pharmaceuticals

of 36

Transcript of Computerised Systems in Pharmaceuticals

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    1/36

    Date Insert onMaster Slide

    Slide 1

    Computerised Systems

    Alfred HuntInspector

    Wholesale Distribution Information Day, 28th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    2/36

    Index

    Slide 228th September 2012

    What is a computerised system

    Updates to EU GDPs

    Expectations

    Case studies

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    3/36

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    4/36

    What is a Computerised System

    Slide 428th September 2012

    GAMP 5

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    5/36

    Slide 5

    Computerised Systems withinWholesaling

    Systems which may impact on productquality

    Provide safety or quality data

    Impact operational reliability

    Maintain regulated data

    A few examples

    Inventory Management Systems

    Sales and Invoicing Systems Temperature Monitoring Systems

    Document Management Systems

    28th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    6/36

    Question

    In the event of a recall how would you identify who yousupplied the affected product to?

    a) By manually checking through all paper invoices

    b) By manually checking a goods-out logbook

    c) By manually checking through electronic records

    d) By running a product search on an electronic inventory /invoicing system?

    Slide 628th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    7/36

    Why New Requirements?

    Patient safety

    Product quality

    Data integrity Where a computerised system replaces a

    manual operation, there should be noresultant decrease in product quality orquality assurance

    Did we build the right system & did webuild it correctly?

    Slide 728th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    8/36Slide 8

    Revised EU Guideline on GDP (Draft)

    Section 3.19

    Before a computerised system is brought into use, itshould be demonstrated through appropriatevalidation or verification studies, that the system is

    capable of achieving the desired results accurately,consistently and reproducibly.

    28th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    9/36Slide 9

    Section 3.20Written detailed description

    Diagrams

    Kept up-to-date

    Principles Objectives

    Security Measures

    System scope

    Main features

    How the system is used

    How the system interacts with other systems

    Revised EU Guideline on GDP (Draft)

    28th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    10/36Slide 10

    Section 3.21

    Data should only be entered or amended by personsauthorised to do so

    Revised EU Guideline on GDP (Draft)

    28th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    11/36

    Slide 11

    Section 3.22

    Data should be secured by physical or electronicmeans and protected against accidental or un-authorised modifications. Stored data should be

    checked periodically for accessibility. Data should beprotected by backing up at regular intervals. Back updata should be retained for a period stated in nationallegislation but at least 5 years at a separate andsecure location.

    Revised EU Guideline on GDP (Draft)

    28th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    12/36

    Section 3.23

    Procedures to be followed if the system fails or breaksdown should be defined. This should include systemsfor the restoration of data.

    Slide 12

    Revised EU Guideline on GDP (Draft)

    28th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    13/36

    Configurable

    Non - Configurable

    What to Do???

    Slide 13

    Risk of Failure / Defects

    Standard Software

    & Hardware

    Custom Software

    & Hardware

    Greater complexity

    Less user experience

    28th September 2012

    Level of Validation

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    14/36

    Life Cycle Approach

    1. Concept(User Requirement Specification - URS)

    2. Project(Functional Specification, Design Specification)

    3. Operation

    (Ongoing maintenance systems)4. Retirement

    GAMP 5

    Supplier InvolvementIs the system being validated the same as the proposedsystem?

    Slide 1428th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    15/36

    User Requirement Specification

    Slide 15

    A document that specifies the requirements for acomputerised system what it should do

    Should be commensurate with level of risk,complexity and novelty of system

    Should be detailed enough to allow for subsequent

    verification of system requirements

    May include operational requirements , functionalrequirements , data requirements, technicalrequirements, interface requirements, performancerequirements, security requirements, maintenance

    requirements, retirement requirements For commercially available systems - may be part

    of purchasing document

    28th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    16/36

    Software Validation

    Slide 16

    Category Validation Approach

    1

    Infrastructure Software

    Record version (include service pack).

    Verify Correct Installation

    3

    Non - Configured

    URS

    Record version and verify installation

    Risk based tests against requirements

    Procedures put in place for maintaining compliance

    Consider auditing supplier for critical and complex applications

    4

    Configured

    As above, plus

    Life cycle approach

    Supplier questionnaireAdequate QMS

    Risk based tests against requirements in a test environmentRisk based tests against requirements within the business process

    5

    Custom

    As above, plus

    Full life cycle documentation

    Design and source code review GAMP 5 Appendix M 4

    28th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    17/36

    Hardware Validation

    Hardware Category 1 - Standard Hardware Installation and connection

    Record model, version number, serial number

    Change Control

    Hardware Category 2 - Custom Built Hardware

    As above plus...

    Design Specification and Acceptance Testing

    Verification of compatibility of interconnected

    hardware Supplier audit

    Slide 1728th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    18/36

    Load Reviews

    Ensuring that your system can cope with alleventualities

    Minimum level through to greater than expectedload

    Repeat if new area / site added

    Growth modelling

    Number of users number of transactions memory capabilities

    Slide 1828th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    19/36

    Suppliers

    Provide / Install / Configure / Integrate / Validate /Maintain / Modify / Retain

    Suitability?

    Competence?

    Technical Agreements

    Audit

    Slide 1928th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    20/36

    Case Study 1

    A wholesaler uses an off-the-shelf software packagefor inventory management and accounting purposes.The system was installed on a standard networked ITsystem. All wholesaling transactions are processedusing the system and it is used as their primarymethod of traceability.

    Slide 2028th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    21/36

    Step 1

    Determine category of system

    Software Category 3 (Non-configurable system)

    Hardware Category 1

    Step 2

    Determine approach to be taken (may include)

    Functionality versus URS

    Record version of software/hardware, verify correct installation

    Allowable users

    Verify data entry capability (product, code, quantity, location)

    Verify processes (orders, picking, FEFO, returns)Verify data is retrievable and accurate

    Run systems side-by-side if upgrading

    Training, Procedures etc

    Slide 2128th September 2012

    Case Study 1

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    22/36

    Case Study 2

    A wholesaler installs a temperature monitoringsystem into their warehouse. The system consists ofwireless probes which send a signal to a relay boxwhich in turn sends a signal to a receiving unit linkedto a PC. The data is uploaded via broadband to thesystem suppliers hosting site. In order to access the

    data the wholesaler must log in to the supplierswebsite.

    Slide 2228th September 2012

    http://cs.dogpile.com/ClickHandler.ashx?du=http://www.faqs.org/photo-dict/photofiles/list/682/1092thermometer.jpg&ru=http://www.faqs.org/photo-dict/photofiles/list/682/1092thermometer.jpg&ld=20120918&ap=1&app=1&c=info.dogpl&s=dogpile&coi=372380&cop=main-title&euip=89.101.136.129&npp=1&p=0&pp=0&pvaid=b40444e105e440cd8d0d3309bfe1b2bb&sid=1830193568.2629679241886.1347978554&vid=1830193568.2629679241886.1331897470.320&fcoi=417&fcop=bottomnav&fpid=2&ep=1&mid=9&hash=76146CE87CA4E13988A4A2A310516DCD
  • 8/13/2019 Computerised Systems in Pharmaceuticals

    23/36

    Step 1

    Determine category of system

    Software - Category 4 (Configurable system)

    Hardware Category 2

    Step 2

    Determine approach to be taken (may include)

    URS / Functional Specification (may be combined)

    Operation and performance of system versus URS & FS

    SLA with supplier, consider audit

    Record version of software, hardware details

    Verify operation of system under load conditions

    User access levels

    Ensure data storage is secureVerify data is retrievable and accurate

    Verify hardware is compatible and functioning (commission andcalibrate)

    Run systems side-by-side if upgrading

    Training, Procedures etc

    Slide 2328th September 2012

    Case Study 2

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    24/36

    Other Requirements

    User procedures

    Training

    Software package documentation

    Hardware package documentation Passwords

    Routinely change (Different cases,numbers, characters)

    Not to be shared!

    Usernames specific for person & not

    ambiguous

    Slide 2428th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    25/36

    Change Management

    Changes to a part of the system pose arisk due to interdependencies

    Does the process owner know if suppliermakes a change? (SLA)

    Version controlled Record, assess, approve and document

    changes

    Slide 2528th September 2012

    http://cs.dogpile.com/ClickHandler.ashx?du=http://3.bp.blogspot.com/_7E-V2lucIao/TO7JKYZl6BI/AAAAAAAAAUQ/ywAWcfC4WUg/s1600/change-management1.jpg&ru=http://3.bp.blogspot.com/_7E-V2lucIao/TO7JKYZl6BI/AAAAAAAAAUQ/ywAWcfC4WUg/s1600/change-management1.jpg&ld=20120918&ap=1&app=1&c=info.dogpl&s=dogpile&coi=372380&cop=main-title&euip=89.101.136.129&npp=1&p=0&pp=0&pvaid=ff6bbad559ce439c8ca7404e8fe7f380&sid=1830193568.2629679241886.1347978554&vid=1830193568.2629679241886.1331897470.320&fcoi=417&fcop=topnav&fpid=2&ep=1&mid=9&hash=F5BD5FFC387E8FCB5CC425D87D5EFD25
  • 8/13/2019 Computerised Systems in Pharmaceuticals

    26/36

    Retention

    5 years (Depending on products!) Regulatory duty

    Preserve content and meaning

    Back-ups (archiving / long term retention) validation of data and media integrity(number of uses etc)

    Restoration (time, routine verification)

    Separate and secure location

    Slide 2628th September 2012

    http://cs.dogpile.com/ClickHandler.ashx?du=http://darrellcreswell.files.wordpress.com/2010/10/throw-out-the-trash.jpg&ru=http://darrellcreswell.files.wordpress.com/2010/10/throw-out-the-trash.jpg&ld=20120918&ap=6&app=1&c=info.dogpl&s=dogpile&coi=372380&cop=main-title&euip=89.101.136.129&npp=6&p=0&pp=0&pvaid=34b5d63e109f4b45aa6f11a9e89c92d6&sid=1830193568.2629679241886.1347978554&vid=1830193568.2629679241886.1331897470.320&fcoi=417&fcop=topnav&fpid=2&ep=6&mid=9&hash=BB95361FC97C3B20140806CE01743BF3
  • 8/13/2019 Computerised Systems in Pharmaceuticals

    27/36

    Ongoing Maintenance

    Ongoing monitoring of systemsperformance

    Error Logs

    Operator training

    Change control

    Maintenance of user manuals / SOPs

    Updates to system

    Slide 2728th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    28/36

    Recovery after failure

    Restoring system to correct state Log file of transaction records

    Incomplete transactions

    Protocols and procedures for testing

    Manual data entry

    Outage investigation

    Slide 2828th September 2012

    http://cs.dogpile.com/ClickHandler.ashx?du=http://www.oxfamblogs.org/fp2p/wp-content/uploads/Confused-Players.jpg&ru=http://www.oxfamblogs.org/fp2p/wp-content/uploads/Confused-Players.jpg&ld=20120918&ap=10&app=1&c=info.dogpl&s=dogpile&coi=372380&cop=main-title&euip=89.101.136.129&npp=10&p=0&pp=0&pvaid=51fb9543cbf549ab82f83ba98bcd2cc0&sid=1830193568.2629679241886.1347978554&vid=1830193568.2629679241886.1331897470.320&fcoi=4&fcop=results-bottom&fpid=2&ep=10&mid=9&hash=6D6267EBDC0E485BEE0288A5E9BB4F32
  • 8/13/2019 Computerised Systems in Pharmaceuticals

    29/36

    Retrospective Validation

    Legacy systems / Reclassification Focus attention on those computerised

    systems with most impact on patientsafety, product quality, and data integrity

    Risk assessments History of use

    Maintenance

    Error logs

    Validation plan / Gap assessment

    Slide 2928th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    30/36

    Risk Management

    Useful for retrospective validation Assess risks Apply controls

    Linked to the protection of the patient

    Level of effort, formality, documentationshould be commensurate with the level ofrisk

    Slide 3028th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    31/36

    Databases

    Databases and repositories should also bevalidated

    Database integrity size?

    Compatibility with other systems

    Slide 3128th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    32/36

    Commercial Spreadsheet Applications

    Highly configurable

    Difficult to validate

    Audit trails

    Changes

    Slide 3228th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    33/36

    Outsourced Services

    E.g. Temperature monitoring Security of data

    Control of data / ownership

    Access

    Service Level Agreements

    Disclaimers

    Slide 3328th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    34/36

    Considerations

    Patient safety is priority Audit trail

    Ease of validation

    Electronic signatures

    Support from supplier

    Slide 3428th September 2012

  • 8/13/2019 Computerised Systems in Pharmaceuticals

    35/36

    Further Guidance!

    Slide 35

    PIC/S Good Practice for Computerised Systems in

    regulated GXP Environments www.picscheme.org

    Eudralex Volume 4 GMP Guide Annex 11:Computerised Systems

    GAMP 5 - Good Automated Manufacturing Practice

    28th September 2012

    http://www.picscheme.org/http://www.picscheme.org/
  • 8/13/2019 Computerised Systems in Pharmaceuticals

    36/36

    Thank you

    [email protected]

    [email protected]

    01-6764971

    mailto:[email protected]:[email protected]://www.imb.ie/http://www.imb.ie/mailto:[email protected]:[email protected]:[email protected]:[email protected]